MedPath

Clinical usefulness of pulse oxi-capnometer, CapnoEye: a multicenter, non-randomized, open -label study for monitoring of EtCO2 in patients with respiratory disease.

Not Applicable
Conditions
Respiratory disease
Registration Number
JPRN-UMIN000026762
Lead Sponsor
Tokyo Medical University, Hachioji Medical Center Respiratory Medicine
Brief Summary

The correlation between PaCO2 measured by arterial blood gas analyzer invasively and EtCO2 measured by pulse oxi-capnometer, CapnoEye, which was investigational device was studied. - Sixty patients in total were enrolled, with age 67.4+/-14.1 (mean+/-SD), 37 (61.7%) males and 23 (38.3%) females. - Their primary diseases are COPD for 21 cases (35.0%), asthma 5 (8.3%), idiopathic interstitial pneumonia 13 (8.3%), and others 26 (43.3%). - Correlation coefficient between PaCO2 and EtCO2 for patients of per protocol set (PPS, n=59) was r=0.815 and its regression line formula was y=1.065x - 4.783 (95% CI 0.864 - 1.266) (p<0.001). - Sub-analysis for PPS showed that high level of correlation coefficient between PaCO2 and EtCO2 was observed in groups of gender, age, inpatient or outpatient, and various type of respiratory diseases. - The study also suggested that correlation between respiration rate and EtCO2 was not clear, and an appropriate pattern of breathing rhythm for each individual patient could effect the accuracy of CapnoEye. - No adverse event and malfunction was observed. - Usefulness of CapnoEye in various respiratory disease care would be expected not only for inpatient but also outpatient as home-care equipment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who are unable to take continuous mouth-breaths at least 8 cycles. 2. Patients who are unable to understand investigator's instructions, e.g. dementia and psychiatric disease. 3. Patients who undergo with Photo Dynamic Therapy and/or defibrillator as combination therapy. 4. Any other cases who are considered as inappropriate for the study by the investigators.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath